Satellos Bioscience is a pioneering regenerative medicine company committed to developing innovative therapeutics that address key muscle disorders. Founded on groundbreaking discoveries in muscle stem-cell polarity, Satellos focuses on restoring the body’s ability to repair and regenerate muscle tissue. The company’s lead program aims to create an oral therapeutic for Duchenne muscular dystrophy by addressing the root causes of the disease. Leveraging its proprietary MyoReGenX discovery platform, Satellos identifies pathways and drug candidates to treat a range of muscle disorders, from rare diseases to broader indications.

Role Description

The Financial Analyst will play a key role in connecting corporate financial strategy with the clinical and R&D programs of a clinical‑stage biotechnology company. This individual will be responsible for tracking and reporting R&D contractual commitments, spend, and accruals, as well as translating clinical progress and comple...